Background and aims: Ferroptosis, a novel concept of programmed cell death proposed in 2012, in kidney disease, has garnered significant attention based on evidence of abnormal iron deposition and ...

and an oral hepcidin mimetic/ferroportin blocker. More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company's website at www.protagonist-inc.com.

This study explores the effects of norfloxacin (NOR) on oxidative damage, iron (Fe) transport, energy metabolism, and immunotoxicity in the intestine of large yellow croaker under Fe stress. The fish ...

Hereditary hemochromatosis is an inherited iron overload disorder caused by inappropriately low hepcidin secretion leading to increased duodenal absorption of dietary iron, most commonly in C282Y ...

Protagonist Therapeutics grants inducement awards to Dr. Newman Yeilding for the role of Executive Vice President, Chief Scientific Officer, under inducement plan. Company's focus on peptide therapeut ...

Van ‘t Hoff Institute for Molecular Sciences, University of Amsterdam, 1098 XH Amsterdam, Netherlands ...